Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2025-12-29 @ 11:11 AM
Study NCT ID:
NCT05214794
Status:
COMPLETED
Last Update Posted:
2024-12-03
First Post:
2022-01-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Open-label, Phase 2 Study to Assess the Efficacy and Safety of Nemolizumab in Subjects With Systemic Sclerosis
Sponsor:
Maruho Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04-20
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-07-30
Completion Date Type:
ACTUAL
First Submit Date:
2022-01-17
First Submit QC Date:
None
Study First Post Date:
2022-01-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-28
Last Update Post Date:
2024-12-03
Last Update Post Date Type:
ACTUAL